» Articles » PMID: 36935893

Excessive Rest Time During Active Phase is Reliably Detected in a Mouse Model of Myotonic Dystrophy Type 1 Using Home Cage Monitoring

Overview
Specialty Psychology
Date 2023 Mar 20
PMID 36935893
Authors
Affiliations
Soon will be listed here.
Abstract

Myotonic dystrophy type 1 (DM1) is a dominantly inherited neuromuscular disease caused by the abnormal expansion of CTG-repeats in the 3'-untranslated region of the Dystrophia Myotonica Protein Kinase (DMPK) gene, characterized by multisystemic symptoms including muscle weakness, myotonia, cardio-respiratory problems, hypersomnia, cognitive dysfunction and behavioral abnormalities. Sleep-related disturbances are among the most reported symptoms that negatively affect the quality of life of patients and that are present in early and adult-onset forms of the disease. DMSXL mice carry a mutated human transgene containing >1,000 CTGrepeats, modeling an early onset, severe form of DM1. They exhibit a pathologic neuromuscular phenotype and also synaptic dysfunction resulting in neurological and behavioral deficits similar to those observed in patients. Additionally, they are underweight with a very high mortality within the first month after birth presenting several welfare issues. To specifically explore sleep/rest-related behaviors of this frail DM1 mouse model we used an automated home cage-based system that allows 24/7 monitoring of their activity non-invasively. We tested male and female DMSXL mice and their wild-type (WT) littermates in Digital Ventilated Cages (DVCR) assessing activity and rest parameters on day and night for 5 weeks. We demonstrated that DMSXL mice show reduced activity and regularity disruption index (RDI), higher percentage of zero activity per each hour and longer periods of rest during the active phase compared to WT. This novel rest-related phenotype in DMSXL mice, assessed unobtrusively, could be valuable to further explore mechanisms and potential therapeutic interventions to alleviate the very common symptom of excessive daytime sleepiness in DM1 patients.

Citing Articles

Muscle-specific gene editing improves molecular and phenotypic defects in a mouse model of myotonic dystrophy type 1.

Izzo M, Battistini J, Golini E, Voellenkle C, Provenzano C, Orsini T Clin Transl Med. 2025; 15(2):e70227.

PMID: 39956955 PMC: 11830570. DOI: 10.1002/ctm2.70227.


Evaluation of the Digital Ventilated Cage® system for circadian phenotyping.

Tir S, Foster R, Peirson S Sci Rep. 2025; 15(1):3674.

PMID: 39880968 PMC: 11779816. DOI: 10.1038/s41598-025-87530-6.


Continuous locomotor activity monitoring to assess animal welfare following intracranial surgery in mice.

Abdollahi Nejat M, Stiedl O, Smit A, Van Kesteren R Front Behav Neurosci. 2024; 18:1457894.

PMID: 39296476 PMC: 11408287. DOI: 10.3389/fnbeh.2024.1457894.


Big data and its impact on the 3Rs: a home cage monitoring oriented review.

Fuochi S, Rigamonti M, OConnor E, de Girolamo P, DAngelo L Front Big Data. 2024; 7:1390467.

PMID: 38831953 PMC: 11144903. DOI: 10.3389/fdata.2024.1390467.

References
1.
Bains R, Wells S, Sillito R, Armstrong J, Cater H, Banks G . Assessing mouse behaviour throughout the light/dark cycle using automated in-cage analysis tools. J Neurosci Methods. 2017; 300:37-47. PMC: 5909039. DOI: 10.1016/j.jneumeth.2017.04.014. View

2.
Laberge L, Gagnon C, Dauvilliers Y . Daytime sleepiness and myotonic dystrophy. Curr Neurol Neurosci Rep. 2013; 13(4):340. DOI: 10.1007/s11910-013-0340-9. View

3.
Liguori C, Spanetta M, Fernandes M, Placidi F, Massa R, Romigi A . The actigraphic documentation of circadian sleep-wake rhythm dysregulation in myotonic dystrophy type 1. Sleep Med. 2021; 88:134-139. DOI: 10.1016/j.sleep.2021.10.003. View

4.
Huguet A, Medja F, Nicole A, Vignaud A, Guiraud-Dogan C, Ferry A . Molecular, physiological, and motor performance defects in DMSXL mice carrying >1,000 CTG repeats from the human DM1 locus. PLoS Genet. 2012; 8(11):e1003043. PMC: 3510028. DOI: 10.1371/journal.pgen.1003043. View

5.
Youn B, Ko Y, Moon S, Lee J, Ko S, Kim J . Digital Biomarkers for Neuromuscular Disorders: A Systematic Scoping Review. Diagnostics (Basel). 2021; 11(7). PMC: 8307187. DOI: 10.3390/diagnostics11071275. View